Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Talimogene_laherparepvec> ?p ?o. }
Showing items 1 to 45 of
45
with 100 items per page.
- Talimogene_laherparepvec abstract "Talimogene laherparepvec (tal im' oh jeen la her" pa rep' vek), often simply called "T-VEC" is a cancer-killing (oncolytic) virus currently being studied for the treatment of melanoma and other advanced cancers. The drug was initially developed by BioVex, Inc. under the name OncoVEXGM-CSF until it was acquired by Amgen in 2011. With the announcement of positive results in March 2013, T-VEC is the first oncolytic virus to be proven effective in a Phase III clinical trial.".
- Talimogene_laherparepvec casNumber "1187560-31-1".
- Talimogene_laherparepvec thumbnail Herpes_simplex_virus_TEM_B82-0474_lores.jpg?width=300.
- Talimogene_laherparepvec wikiPageExternalLink oncolytic-immunotherapy.
- Talimogene_laherparepvec wikiPageExternalLink oncolytic-immunotherapy.
- Talimogene_laherparepvec wikiPageID "38686504".
- Talimogene_laherparepvec wikiPageRevisionID "601024235".
- Talimogene_laherparepvec caption "Transmission electron micrograph of an unmodified herpes simplex virus".
- Talimogene_laherparepvec casNumber "1187560".
- Talimogene_laherparepvec chemicalDescription "ICP34.5-, ICP47-deleted herpes simplex virus 1 incorporating the human GM-CSF gene".
- Talimogene_laherparepvec chemicalFormula "JS1 34.5-hGMCSF 47- pA-".
- Talimogene_laherparepvec drugName "Talimogene laherparepvec".
- Talimogene_laherparepvec legalStatus "Investigational".
- Talimogene_laherparepvec pregnancyCategory "TBD".
- Talimogene_laherparepvec routesOfAdministration "Injection".
- Talimogene_laherparepvec usanName "Talimogene laherparepvec".
- Talimogene_laherparepvec subject Category:Amgen.
- Talimogene_laherparepvec subject Category:Antigen_presenting_cells.
- Talimogene_laherparepvec subject Category:Biotechnology.
- Talimogene_laherparepvec subject Category:Cancer_treatments.
- Talimogene_laherparepvec subject Category:Cancer_vaccines.
- Talimogene_laherparepvec subject Category:Carcinoma.
- Talimogene_laherparepvec subject Category:Cytokines.
- Talimogene_laherparepvec subject Category:Experimental_cancer_drugs.
- Talimogene_laherparepvec subject Category:Experimental_cancer_treatments.
- Talimogene_laherparepvec subject Category:Head_and_neck_cancer.
- Talimogene_laherparepvec subject Category:Immunology.
- Talimogene_laherparepvec subject Category:Immunomodulating_drugs.
- Talimogene_laherparepvec subject Category:Integumentary_neoplasia.
- Talimogene_laherparepvec subject Category:Medical_treatments.
- Talimogene_laherparepvec subject Category:Melanoma.
- Talimogene_laherparepvec subject Category:Oncology.
- Talimogene_laherparepvec subject Category:Simplexviruses.
- Talimogene_laherparepvec subject Category:Virotherapy.
- Talimogene_laherparepvec type Drug.
- Talimogene_laherparepvec type FunctionalSubstance.
- Talimogene_laherparepvec comment "Talimogene laherparepvec (tal im' oh jeen la her" pa rep' vek), often simply called "T-VEC" is a cancer-killing (oncolytic) virus currently being studied for the treatment of melanoma and other advanced cancers. The drug was initially developed by BioVex, Inc. under the name OncoVEXGM-CSF until it was acquired by Amgen in 2011. With the announcement of positive results in March 2013, T-VEC is the first oncolytic virus to be proven effective in a Phase III clinical trial.".
- Talimogene_laherparepvec label "Talimogene laherparepvec".
- Talimogene_laherparepvec sameAs m.0117qddr.
- Talimogene_laherparepvec sameAs Q7679524.
- Talimogene_laherparepvec sameAs Q7679524.
- Talimogene_laherparepvec wasDerivedFrom Talimogene_laherparepvec?oldid=601024235.
- Talimogene_laherparepvec depiction Herpes_simplex_virus_TEM_B82-0474_lores.jpg.
- Talimogene_laherparepvec isPrimaryTopicOf Talimogene_laherparepvec.
- Talimogene_laherparepvec name "Talimogene laherparepvec".
